Sort
82,697 grants matching “vaccine development”
Vaccines and Therapeutics for Anthrax
$1,066,759Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Viral/Immune parameters of Dengue and WNV in donors: blood safety implications
$1,066,706Michael Paul Busch · Vitalant · RC2 · FY2010 · HL
Center of Excellence for High Throughput Proteogenomic Characterization
$1,066,337Steven A. Carr · Broad Institute, Inc. · U24 · FY2023 · CA
Eliciting VRC01-like bNAbs by Specifically Designed Env Immunogens
$1,066,201Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2014 · AI
Task D04:World Reference Center for Emerging Viruses and Arboviruses
$1,065,853Alan D.t. Barrett · University Of Texas Med Br Galveston · N01 · FY2014 · AI
Development of botulinum neurotoxin immunotherapy
$1,065,728University Of California San Francisco · U01 · FY2005 · AI
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
$1,065,423Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AI
Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1
$1,065,397Pamela J Bjorkman · California Institute Of Technology · P01 · FY2021 · AI
Functional genomic analysis of the CD8 T cell response to HIV vaccines in
$1,065,338William Nicholas Haining · Dana-Farber Cancer Inst · R01 · FY2011 · AI
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$1,065,311Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
NINDS/UC Davis NeuroMab Hybridoma Facility
$1,064,984James S Trimmer · University Of California At Davis · U24 · FY2007 · NS
Preclinical Studies of Bunyaviruses
$1,064,872Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
SMALL MOLECULE SCREENING TO IDENTIFY INHIBITORS OF FILOVIRAL
$1,064,841Arnab Basu · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI
Task V06: Immunogenicity and efficacy testing of COVID-19 vaccine candidates in nonhuman primates
$1,064,710Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2021 · AI
New Approaches To Passive Immunoprophylaxis
$1,064,532Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Profiling cancer neoantigen repertoires and validating immunotherapy targets
$1,064,486Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
Project-002
$1,064,411Arnab Basu · Georgia State University · U19 · FY2017 · AI
SBIR Phase II: Development of Polymer Gel-Based Indicators to Monitor the Exposure of Shipments of Pharmaceuticals to Harmful Temperatures
$1,063,975Bani H Cipriano · Prasidiux Llc · · FY2014 · TIP
Resource for NMR Molecular Imaging of Proteins
$1,063,830University Of California San Diego · P41 · FY2004 · EB
Papillomavirus Virion Proteins and Vaccines
$1,063,732Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Omics, Bioinformatics, and Data Management Core
$1,063,373Michael J Gale · Oregon Health & Science University · P01 · FY2022 · AI
Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive
$1,063,088B. Kim Lee Sim · Protein Potential, Llc · R01 · FY2013 · AI
CENTER FOR COMPUTATIONAL MASS-SPECTROMETRY
$1,062,982Pavel A Pevzner · University Of California, San Diego · P41 · FY2010 · RR
Center for Computational Mass-Spectrometry
$1,062,982Pavel A Pevzner · University Of California, San Diego · P41 · FY2010 · RR
Immunity to Pneumonic Tularemia
$1,062,784Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI